About: Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article by Mark Agulnik et al published September 2007 in Journal of Clinical Oncology

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 2007 (uk) im September 2007 veröffentlichter wissenschaftlicher Artikel (de) article by Mark Agulnik et al published September 2007 in Journal of Clinical Oncology (en)
publication date	wds:Q57272626-4CFD1A30-9C89-4364-B220-40115E597F55
publication date	2007-09-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57272626-57F2A8B9-764E-401E-A987-B74930D76E1F
language of work or name	English
author name string	wds:Q57272626-1B7CEBF0-4F0E-46EC-8705-CA4AC3A2B501 wds:Q57272626-3552310F-469A-48D8-B64D-339682BC60BF wds:Q57272626-3A09C1BA-2E17-4F57-A759-2E2A25F3AC36 wds:Q57272626-3D6D16C4-5DC2-4513-98C1-0AFE937C59E0 wds:Q57272626-55802FB2-7F5B-4190-B155-3A5455C1E56F wds:Q57272626-55CC1012-6A18-47AE-97AD-4DBA83260723 wds:Q57272626-57108F1D-6F51-41A6-9F7A-542E88E713E8 wds:Q57272626-5B4B0D91-6871-47CA-9C4A-8E27F6205082 wds:Q57272626-709831C7-522E-4840-B815-971423F16911 wds:Q57272626-999E239E-530F-48E7-84D3-B8469731890E wds:Q57272626-BBC7D553-2061-4D87-990B-F5CD4222EA40 wds:Q57272626-C51D6B96-1468-4C91-A839-413D3A772FB7 wds:Q57272626-F8857F90-4032-4FD5-816A-232208885B5F
author name string	Eric Winquist Mark Agulnik Manijeh Daneshmand Shirley Brown James Ho Ian Lorimer Scott Laurie Lillian L. Siu Roger B. Cohen Gregory R. Pond Sebastien J. Hotte Eric X. Chen Janet E. Dancey
rdfs:label	Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands (en) Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands (nl)
skos:prefLabel	Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands (en) Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands (nl)
name	Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands (en) Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands (nl)
author	wds:Q57272626-4362939F-CC6D-42BC-8592-C4B65BA4064B wds:Q57272626-569B0B60-3FE8-4B8D-A080-EF210761C127 wds:Q57272626-C685903F-8B34-45C8-9295-D55F3ACCC496 wds:Q57272626-F7CE3750-D41E-4160-B836-3F8A35926154
author	Everett E Vokes Ezra E Cohen D. Neil Hayes Ming-Sound Tsao
title	wds:Q57272626-66D3F7E2-41AE-49FE-977F-C6222E704A05
title	Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands (en)
page(s)	wds:Q57272626-B25E74CC-FA62-4182-A39E-11356C10C322
page(s)	3978-3984
instance of	wds:Q57272626-52376987-6F45-48B0-814A-FDB598585907
instance of	scholarly article
main subject	wds:Q57272626-AC8F26CE-4D89-413A-B0A7-1887973F8235
main subject	adenoid cystic carcinoma
PubMed ID	wds:Q57272626-FFAB44F8-F602-4C01-B550-0EB01805ACE8
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17761983
PubMed ID	17761983
published in	wds:Q57272626-6A558FD5-C271-48AA-9E6C-3BA84439D413
published in	Journal of Clinical Oncology
issue	wds:Q57272626-91769157-5AE0-489E-9B93-146CE1B7E254
volume	wds:Q57272626-3662CE4A-7818-40B1-97A3-7E1CD2B9A81C
issue	25
volume	25
DOI	wds:Q57272626-78EFF1DF-6CD7-4302-8CAD-48630D204BE8
DOI	http://dx.doi.org/10.1200/JCO.2007.11.8612
DOI	10.1200/JCO.2007.11.8612
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57272626
is cites work of	Systemic therapies for recurrent and/or metastatic salivary gland cancers Management of salivary gland tumors. Salivary gland cancers: biology and molecular targets for therapy. Diagnosis and management of parotid carcinoma with a special focus on recent advances in molecular biology Recent trends in the management of minor salivary gland carcinoma. Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: a review Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer Aberrations of MET are associated with copy number gain of EGFR and loss of PTEN and predict poor outcome in patients with salivary gland cancer Genomic landscape of salivary gland tumors Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma. Targeting the EGFR signaling pathway in cancer therapy Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review Targeting the disordered C terminus of PTP1B with an allosteric inhibitor Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2 A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets The mutational landscape of adenoid cystic carcinoma Human epidermal receptor 2-amplified salivary duct carcinoma: regression with dual human epidermal receptor 2 inhibition and anti-vascular endothelial growth factor combination treatment Oncocytoma of the parotid gland: a case report and review of the literature Lapatinib: a sword with two edges Targeted treatment of head and neck squamous-cell carcinoma: potential of lapatinib RadioImmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximab Salivary tumours Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib The molecular pathogenesis of head and neck cancer Prioritizing phase I treatment options through preclinical testing on personalized tumorgraft Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux® and particle therapy]. Molecular target approaches in head and neck cancer: epidermal growth factor receptor and beyond Promising newer molecular-targeted therapies in head and neck cancer Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software